As shown in Figure 1D, EGCG treatment at 10 μM still exhibited capability to induce the maximal expression of ERα expression compared with the additional concentrations of EGCG suggesting 10 μM of EGCG is the optimal concentration to induce ERα reactivation in ERα-negative MDA-MB-231 breast cancer cells. This evidence concerns the gene ESR1 and breast cancer.